Anmelden/Registrieren
Erscheinungsjahr:
 
Zurück zur geteilten Ansicht
G. Schwartsmann

Veröffentlichungen von G. Schwartsmann zu Schwartsmann, G. ->
weitere Veröffentlichungen von G. Schwartsmann:
Growth inhibitory effects of 5-aza-2'-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation induction (1986)
Growth inhibitory effects of 5-aza-2'-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation induction (1986)
Double-minute chromatin bodies in HL-60 leukemia cells sensitive and resistant to differentiation inducing agents (1987)
Essential drugs for cancer therapy: A World Health Organization consultation (1999)
A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer (2000)
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer (1997)
Abstract (1992)
Veröffentlichungen zu Schwartsmann, G.
Zurück zur geteilten Ansicht
Verfasser Titel Jahr absteigend sortierenaufsteigend sortieren
zeige Details
1
Levva, A., Schwartsmann, G., ... Growth inhibitory effects of 5-aza-2'-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation induction
in: Biochemical and Biophysical Research Communications, in: Biochemical and Biophysical Research Communications . - Amsterdam : Elsevier, ISSN 0006-291X, ZDB-ID 1461396-7 Vol. 141, No. 2 (1986), p. 629-635
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
2
Levva, A., Schwartsmann, G., ... Growth inhibitory effects of 5-aza-2'-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation induction
in: Biochemical and Biophysical Research Communications, in: Biochemical and Biophysical Research Communications . - Amsterdam : Elsevier, ISSN 0006-291X, ZDB-ID 1461396-7 Vol. 141, No. 2 (1986), p. 629-635
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
3
Schwartsmann, G., Madan, K., ... Double-minute chromatin bodies in HL-60 leukemia cells sensitive and resistant to differentiation inducing agents
in: Cell Biology International Reports, in: Cell Biology International Reports . - Amsterdam : Elsevier, ISSN 0309-1651, ZDB-ID 2197149-3 Vol. 11, No. 9 (1987), p. 651-655
Zugang: zum Volltext
ähnliche Vorschläge
1987
zeige Details
4
Sikora, K., Advani, S., ... Essential drugs for cancer therapy: A World Health Organization consultation
in: Annals of oncology , ISSN 1569-8041, Vol. 10 (4. 1999), p. 385-390
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
5
Schwartsmann, G., Schunemann, H., ... A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with...
in: Investigational new drugs , ISSN 1573-0646, Vol. 18 (1. 2000), p. 83-91
Zugang: zum Volltext
ähnliche Vorschläge
2000
zeige Details
6
Murad, A.M., Guimaraes, R.C., ... Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 45 (1. 1997), p. 47-53
Zugang: zum Volltext
ähnliche Vorschläge
1997
zeige Details
7
Mache, Ch., Urban, Ch., ... Abstract
in: Annals of hematology , ISSN 1432-0584, Vol. 65 (1. 1992), p. A1
Zugang: zum Volltext
ähnliche Vorschläge
1992